Clinical Trials Directory

Trials / Unknown

UnknownNCT02380339

A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Uncontrolled diabetes is associated with increased risk for micro-vascular complication. Hypoglycemia is one of the major barriers in achieving good glucose control. Hypoglycemia is associated with a range of unpleasant symptoms including palpitations, tremor, hunger, sweating, confusion, difficulties in thinking as well as other idiosyncratic symptoms. Fear of hypoglycemia (FOH) refers to phobic avoidance reactions associated with hypoglycemia FOH may increase behavioral attempts to avoid hypoglycemia including decreased consumption of insulin and/or increased consumption of carbohydrates, resulting in poor glycemic control and an increased risk of diabetic complication. In this study, the investigators present a novel system, which simultaneously employs BioFeedback and Virtual Reality in order to cope with fear of hypoglycemia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsych-Educational session and virtual realityPsych-Educational session and virtual reality
BEHAVIORALPsych-Educational and BF sessionsPsych-Educational and BF sessions

Timeline

Start date
2018-03-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2015-03-05
Last updated
2019-09-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02380339. Inclusion in this directory is not an endorsement.